Physicist Thomas Sheahen probes the limit of science’s ability to interpret unobservable phenomena like the multiverse, suggesting techniques for reconciling empirical inquiry with qualitative aspects of reality.
Read More
In our second episode about CRISPR gene editing technology, tech entrepreneur Joe Chiarella asks who is guiding these new multi-billion-dollar companies and balancing the goals of researchers and product makers against the best interests of society.
Read More
Hospital CFO Paul Babcock explains why health care economics are not structured to serve either patients or health care employees. He challenges this status quo with the possibility of a more ethical system.
Read More
Geneticist Fr. Nicanor Austriaco discusses the science behind CRISPR gene editing technology and the challenges it presents to ethicists.
Read More